Market Value1,306,113,979
Total Holdings50
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SIBN / SI-BONE, Inc.
SLP / Simulations Plus, Inc.
KRMD / KORU Medical Systems, Inc.
ATEC / Alphatec Holdings, Inc.
TCMD / Tactile Systems Technology, Inc.
SWAV / Shockwave Medical, Inc.
IDYA / IDEAYA Biosciences, Inc.
NEO / NeoGenomics, Inc.
HCA / HCA Healthcare, Inc.
OSCR / Oscar Health, Inc.
TMDX / TransMedics Group, Inc.
DYN / Dyne Therapeutics, Inc.
INSM / Insmed Incorporated
VERA / Vera Therapeutics, Inc.
PODD / Insulet Corporation
NARI / Inari Medical, Inc.
SCTL / Societal CDMO, Inc.
AVTR / Avantor, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
IRTC / iRhythm Technologies, Inc.
EVH / Evolent Health, Inc.
INSP / Inspire Medical Systems, Inc.
STVN / Stevanato Group S.p.A.
PHLT / Performant Healthcare, Inc.
HCAT / Health Catalyst, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
GH / Guardant Health, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
ATRC / AtriCure, Inc.
AXGN / Axogen, Inc.
LIVN / LivaNova PLC
PRVA / Privia Health Group, Inc.
OPRX / OptimizeRx Corporation
RCM / R1 RCM Inc.
PCVX / Vaxcyte, Inc.
THC / Tenet Healthcare Corporation
MODN / Model N, Inc.
TELA / TELA Bio, Inc.
PRTA / Prothena Corporation plc
OGN / Organon & Co.
BMRN / BioMarin Pharmaceutical Inc.
PDCO / Patterson Companies, Inc.
MDT / Medtronic plc
BAYZF / Bayer Aktiengesellschaft
IART / Integra LifeSciences Holdings Corporation
XRAY / DENTSPLY SIRONA Inc.
ENOV / Enovis Corporation
RVTY / Revvity, Inc.
IWO / iShares Trust - iShares Russell 2000 Growth ETF
TAK / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
ABBV / AbbVie Inc.
UTHR / United Therapeutics Corporation
LH / Labcorp Holdings Inc.
AXNX / Axonics, Inc.
ANTX / AN2 Therapeutics, Inc.
QGEN / Qiagen N.V.
FMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
JNJ / Johnson & Johnson
GSK / GSK plc - Depositary Receipt (Common Stock)
GILD / Gilead Sciences, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
TECH / Bio-Techne Corporation
NVS / Novartis AG - Depositary Receipt (Common Stock)
BIIB / Biogen Inc.
SNN / Smith & Nephew plc - Depositary Receipt (Common Stock)
KRTX / Karuna Therapeutics, Inc.
KIDS / OrthoPediatrics Corp.
HUM / Humana Inc.
EXEL / Exelixis, Inc.
BHVN / Biohaven Ltd.
CNC / Centene Corporation
QDEL / QuidelOrtho Corporation
HALO / Halozyme Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
NTRA / Natera, Inc.
PLRX / Pliant Therapeutics, Inc.
SONXD / Sonendo, Inc.
ALPN / Alpine Immune Sciences, Inc.
FNA / Paragon 28, Inc.
XENE / Xenon Pharmaceuticals Inc.
ANAB / AnaptysBio, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
TNDM / Tandem Diabetes Care, Inc.
VTRS / Viatris Inc.
PEN / Penumbra, Inc.